ONO-2808
- Generic Name
- ONO-2808
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
Phase 2
Active, not recruiting
- Conditions
- Multiple System Atrophy (MSA)
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 92
- Registration Number
- NCT05923866
- Locations
- 🇺🇸
The Parkinson's Movement and Disorder Institute, Fountain Valley, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸David Geffen School of Medicine at UCLA, Los Angeles, California, United States
A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of ONO-2808-01 in Healthy Participants
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2021-12-30
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 94
- Registration Number
- NCT04578028
- Locations
- 🇬🇧
Parexel International Early Phase Clinical Unit (EPCU), London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath